Literature DB >> 21282441

Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Motoyasu Miyazaki, Tohru Takata, Hisae Yoshimura, Akira Matsunaga, Daiki Ohta, Hiroyasu Ishikura, Maki Futo, Shuji Hara, Hidetoshi Kamimura, Kazuo Tamura, Dung Ngo, Brian T Tsuji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21282441      PMCID： PMC3067189          DOI： 10.1128/AAC.01536-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

Review 1.  Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.

Authors:  George Sakoulas; Robert C Moellering; George M Eliopoulos
Journal:  Clin Infect Dis       Date:  2006-01-01       Impact factor: 9.079

2.  Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Pamela A Moise; George Sakoulas; Alan Forrest; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Authors:  T P Lodise; J Graves; A Evans; E Graffunder; M Helmecke; B M Lomaestro; K Stellrecht
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

4.  Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

Authors:  Pamela A Moise-Broder; George Sakoulas; George M Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2004-05-21       Impact factor: 9.079

5.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

6.  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

7.  Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Authors:  Feng-Yee Chang; James E Peacock; Daniel M Musher; Patricia Triplett; Brent B MacDonald; Joseph M Mylotte; Alice O'Donnell; Marilyn M Wagener; Victor L Yu
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889
  7 in total
  8 in total

1.  High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.

Authors:  Ilker Uçkay; Louis Bernard; Marta Buzzi; Stephan Harbarth; Patrice François; Elzbieta Huggler; Tristan Ferry; Jacques Schrenzel; Adriana Renzoni; Pierre Vaudaux; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

2.  Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Masaru Shimizu; Toshihito Mihara; Junya Ohara; Keita Inoue; Mao Kinoshita; Teiji Sawa
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Nicholas S Britt; Nimish Patel; Rebecca T Horvat; Molly E Steed
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

4.  Activated ClpP kills persisters and eradicates a chronic biofilm infection.

Authors:  B P Conlon; E S Nakayasu; L E Fleck; M D LaFleur; V M Isabella; K Coleman; S N Leonard; R D Smith; J N Adkins; K Lewis
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

5.  Rapid and easy detection of low-level resistance to vancomycin in methicillin-resistant Staphylococcus aureus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Kota Asakura; Takuya Azechi; Hiroshi Sasano; Hidehito Matsui; Hideaki Hanaki; Motoyasu Miyazaki; Tohru Takata; Miwa Sekine; Tomoiku Takaku; Tomonori Ochiai; Norio Komatsu; Keigo Shibayama; Yuki Katayama; Koji Yahara
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

6.  Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.

Authors:  Yuki Katayama; Takuya Azechi; Motoyasu Miyazaki; Tohru Takata; Miwa Sekine; Hidehito Matsui; Hideaki Hanaki; Koji Yahara; Hiroshi Sasano; Kota Asakura; Tomoiku Takaku; Tomonori Ochiai; Norio Komatsu; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Survive in Kupffer Cells and Exhibit High Virulence in Mice.

Authors:  Takuto Oyama; Motoyasu Miyazaki; Michinobu Yoshimura; Tohru Takata; Hiroyuki Ohjimi; Shiro Jimi
Journal:  Toxins (Basel)       Date:  2016-06-30       Impact factor: 4.546

8.  Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.

Authors:  Atsushi Komoto; Takayoshi Maiguma; Daisuke Teshima; Tetsuhiro Sugiyama; Yuto Haruki
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.